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ABSTRACT Molecular cancer therapy relies on interstitial diffusion for drug distribution in solid tumors. A mechanistic under-
standing of how tumor components affect diffusion is necessary to advance cancer drug development. Yet, because of limitations
in current techniques, it is unclear how individual tissue components hinder diffusion. We developed multiscale ﬂuorescence
recovery after photobleaching (MS-FRAP) to address this deﬁciency. Diffusion measurements facilitated by MS-FRAP distin-
guish the diffusive hindrance of the interstitial versus cellular constituents in living tissue. Using multiscale diffusion measure-
ments in vivo, we resolved the contributions of these two major tissue components toward impeding diffusive transport in solid
tumors and subcutaneous tissue in mice. We further used MS-FRAP in interstitial matrix-mimetic gels and in vivo to show the
inﬂuence of physical interactions between collagen and hyaluronan on diffusive hindrance through the interstitium. Through
these studies, we show that interstitial hyaluronan paradoxically improves diffusion and that reducing cellularity enhances
diffusive macromolecular transport in solid tumors.INTRODUCTION
Diffusion is a significant mechanism for extravascular
molecular transport in vivo, and is affected by both the visco-
elasticity of the interstitial matrix and the hindrance of large
bodies such as cells (1,2). These factors are important in
wide-ranging normal and disease states, from extrasynaptic
neuronal signaling to cancer therapy. In solid tumors,
elevated interstitial pressure abrogates convective transport,
limiting molecular transport to passive diffusion (3–5).
However, the constituents of tumors impede the transport
of nanomedicine, including antibodies, oncolytic viruses,
and nanoparticles (6). A mechanistic understanding of the
barriers to drug transport in a target tissue would advance
the development of adjuvant therapies to potentiate cancer
drugs. Yet it is currently impossible to distinguish the diffu-
sive hindrance of interstitial matrix from that of cells to iden-
tify which components of a tissue are significant barriers to
drug penetration.
No single technique currently exists for simultaneous char-
acterization of the primary inhibitors of diffusion in living
tissues: the interstitial matrix and cells. The effects of distinct
interstitial matrix phases on macromolecular diffusion can be
discernedwithmultiphoton fluorescence correlation spectros-
copy (MP-FCS) (7,8), which measures on single-micron
length scales, but its application in vivo is limited by sensi-
tivity to sample movement. Multiphoton fluorescence
recovery after photobleaching (MP-FRAP) (9) possesses the
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0006-3495/09/07/0330/7 $2.00same resolution and is more robust to noise, giving greater
potential for characterizing the nature of the interstitial
phases, but its ability to measure two-phase diffusion
in vivo is untested. Furthermore, these techniques cannot
capture the influence of cells on bulk diffusion. Spatial Four-
ier analysis FRAP (SFA-FRAP) and similar methods, which
quantify diffusion on length scales of tens of microns,
measure diffusion properties influenced by both cells and
the interstitial matrix. Yet these techniques are limited in reso-
lution, unable to distinguish interstitial versus cellular contri-
butions to diffusion (10). Recently developed laser-scanning
FRAP techniques (11) measure diffusion in regions of scal-
able size; however, these measurements are dominated by
diffusion along the minimum bleach dimension, generally
~5 mm. Thus, the direct effects of cell geometry on diffusion
in vivo have not been quantified except in tissues with fully
aligned cell anisotropies (12) or estimations based on mathe-
matical models (13).
To address this inability to determine how each tissue
component affects diffusion, we developed a multiscale
approach for studying molecular diffusion in vivo that
combines SFA-FRAP and MP-FRAP in an excitation-
confocal manner. This method, multiscale fluorescence
recovery after photobleaching (MS-FRAP), merges the
advantages of both, facilitating path length-dependent diffu-
sion measurements over multiple length scales. MS-FRAP
permits diffusion measurements in vivo that simultaneously
characterize the separate effects of three tissue components:
two interstitial matrix phases and the cellular constituents.
doi: 10.1016/j.bpj.2009.03.064
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Solution and agarose gel systems
Solutions of fluorescent probes (Sigma-Aldrich, St. Louis, MO) in deionized
water are prepared from salts and filtered when necessary. Solution measure-
ments are carried out in 50 mm path-length glass microslides (VitroCom,
Mountain Lakes, NJ). Agarose gels are made by warming water or fluoro-
phore solution to 90C and slowly adding agarose powder (Sigma-Aldrich)
to the desired concentration. To create a gel-sol interface, a mixture of 5%
agarose powder in deionized water is used to partially fill a 400 mm path-
length glass microslide. The microslide is then heated at 90C until the
gel becomes transparent. A solution of fluorophore is then added to the other
side of the microslide to form an interface. Measurements are carried out
after at least 2 h of incubation to allow partitioning of the fluorescent probe
between phases. Because there is a difference in the intensity of fluorescence
in the gel and sol phases caused by partitioning, the exact location of the
interface is determined by measuring fluorescence photon counts on either
side of the interface. The laser is gradually moved to the sample regions,
where the average of these two count levels is detected at the interface. To
image the bleach volumes, measurements are made in a 10% agarose gel con-
taining 2 MDa molecular mass fluorescein isothiocyanate dextran (FITC-
dextran2M) placed in a deep-well slide (VWR International, West Chester,
PA). To characterize the point-spread function, a sample with fixed subreso-
lution beads (TetraSpeck Size Kit; Molecular Probes, Eugene, OR) is used.
Animals and tumor models
Dorsal skinfold chambers (DSC) are implanted in adult male severe
combined immunodeficient (SCID) mice as described previously (14).
Tumor chunks are implanted in the center of the chamber 2–3 days after
the initial surgery. Human soft tissue sarcoma (HSTS26T) or human colo-
rectal adenocarcinoma (LS174T) cells are transplanted from subcutaneously
grown tumors in male SCID mice. Xenotransplanted tumors are allowed to
grow to at least 3.0 mm in diameter before measurements are carried out. All
experiments are carried out with the approval of the Institutional Animal
Care and Use Committee at the Massachusetts General Hospital.
Interstitial matrix-mimetic collagen/hyaluronan
gels
Gels are formed using rat tail collagen-I (HC collagen I; BD Bioscience, San
Jose, CA) and rooster comb hyaluronic acid (Sigma-Aldrich) solutions at
starting concentrations of 10 mg/mL and 5.0 mg/mL, respectively. The
collagen solution is first mixedwith a fluorescent probe at the desired concen-
tration. The collagen solution is then neutralized with 2.3% by volume 1 N
NaOH in accordance to the manufacturer’s protocol. Neutralization of the
hyaluronic acid solution is attained with 10% by volume 1 N NaOH. The hy-
aluronic acid solution is then added to the collagen solution in the desired
concentration ratio and vortexed vigorously for 7–10 s. The resultingmixture
is pipetted onto glass coverslips in 30 mL drops immediately for lower-
concentration gels (10 mg/mL collagen or less). For higher-concentration
gels, it is centrifuged at 21,000  g and 4C for 15 min and then deposited.
The droplets are incubated in a humidified environment at 37C for 60 min
to complete the gelation process. Gel imaging is carried out by inverting
the glass coverslip onto a deep-well glass slide and sealing the contact with
water. The gel droplet can then be imaged through the coverslip.
SFA-FRAP
The SFA-FRAP experiments are carried out as described previously (10),
using the 488 nm-line of an Argon-ion laser (Innova 300; Coherent, Santa
Clara, CA) and 40 (0.75 NA; Carl Zeiss MicroImaging, Thornwood,
NY) water-immersion objective. Briefly, a mercury lamp (60010; LOT-Oriel
Group, Darmstadt, Germany) is used to excite a region of the sample to be
studied while images are collected with an intensified CCD camera (C-2400,Hamamatsu, Bridgewater, NJ). The sample is exposed to a brief (<200 ms),
intense pulse of 488 nm laser light (800 mW) that irreversibly photobleaches
fluorophores throughout the focal volume and, to an extent, the optical axis.
Recovery of the fluorescence is measured by taking additional images over
several minutes depending on the probe size. Diffusion coefficient values are
obtained by carrying out a spatial Fourier transform of the images and fitting
a model exponential recovery curve to the change in amplitude of the lowest
six spatial frequencies over time with nonlinear least squares. An immobile
fraction is taken into account in the model but does not affect the measured
diffusion coefficient (Fig. S1 in the Supporting Material). Data acquisition
and analyses are carried out using a custom code developed in LabView
(National Instruments, Austin, TX). Recovery curves or spatial frequencies
containing anomalies such as bleaching over time are not analyzed.
MP-FRAP
The MP-FRAP experiments are based on theory and methodology described
previously (9), using a Ti:Sapphire laser (Mai-Tai Broadband; Spectra-
Physics, Mountain View, CA) at 800 nm, a 40 (0.75 NA; Zeiss)
water-immersion objective, and photon-counting photomultiplier tubes
(H7421-40; Hamamatsu). Experiments are carried out with a custom-built
multiphoton microscope containing an Axioskop upright microscope
(Carl Zeiss) and Bio-Rad MRC-600 confocal laser scanner (Carl Zeiss).
The laser is focused at a fixed spot (nonscanning) in the sample at low power
(~5–10 mW at the sample) to monitor fluorescence without photobleaching.
Photons are counted and binned using a multichannel scaler and averager
(SR430, Stanford Research Systems, Sunnyvale, CA). An electro-optic
modulator (KD*P Pockels’ cell; ConOptics, Danbury, CT) and digital delay
generator (DG535; Stanford Research Systems) rapidly modulate the laser
power using custom-built hardware and a user interface developed in Lab-
View. In a single bleaching pulse, the laser power is increased briefly
(<100 ms) to a more intense pulse of light (~40–60 mW at the sample)
causing irreversible photobleaching in the focal volume. The laser power
is returned to the original low power and fluorescence recovery is monitored
over several milliseconds, depending on the probe size. Because of the low
concentration of fluorophores within the focal volume, the bleach and
recovery process is repeated hundreds of times to improve signal to noise.
Fractional diffusion coefficients are obtained by fitting a two-component
recovery model, selected over an anomalous diffusion model based on estab-
lished criteria (Fig. S2) (9), to the change in amplitude of fluorescence over
time with nonlinear least-squares fitting, incorporating a trust-region algo-
rithm using MATLAB (The MathWorks, Natick, MA). When two identical
diffusion coefficients are obtained from a two-component fit, diffusion is
considered to be one component with a fraction of 1.0.
MP-FCS
The MP-FCS experiments are carried out as described previously (7), using
the same microscope setup as MP-FRAP. Briefly, the laser (~5–10 mW at
the sample) is focused at a fixed spot in the sample. Intensity fluctuations
over a period of 30–60 s measured with two photomultiplier tubes are
cross-correlated via a digital correlator card (Flex02-12B; Correlator.com,
Bridgewater, NJ) to determine probabilities for average residence times of
probes in the focal volume. Fitting a model described previously (7) to
this correlation function extracts diffusion coefficients and populations (frac-
tions) using a nonlinear least-squares trust-region algorithm (MATLAB).
MS-FRAP measurements in gels
The gels are formulated as described with FITC-IgG at a final concentration
of ~1 mM. Fifteen MS-FRAP diffusion measurements at a depth of 50 mm in
random locations are made in each gel type (n¼ 3). The following procedure
is used for each spot studied: 1), we image the spot using multiphoton
microscopy (MPM); 2), we park the Ti:Sapphire laser along the optical
axis of the microscope and carry out MP-FRAP; 3), we re-image the spot
with MPM to ensure that no sample movement occurred; 4), we switchBiophysical Journal 97(1) 330–336
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FRAP; and 5), we again re-image the spot with MPM to ensure that no
movement occurred. In extremely rare cases of sample movement, a new
location is selected for measurement.
MS-FRAP measurements in vivo
Measurements aremade in size-matched tumors of ~3mm in diameter or at the
center of the chamber for normal tissue. The tissues are microinjected at
a depth of 500 mm with 1 mL of 1 mg/mL FITC-IgG solution at a rate of
~0.1 mL/min. Six MS-FRAP diffusion measurements at a depth of 50 mm
are made at different regions in each tissue. The following procedure is
used for each spot studied: 1), we image the spot using multiphoton micros-
copy; 2),we park theTi:Sapphire laser along the optical axis of themicroscope
and collectMP-FRAP data; 3), we re-image the spot withMPM to ensure that
no photodamage or sample movement occurred; 4), we switch to the light
paths for SFA-FRAP and collect SFA-FRAP data; and 5), we again re-image
the spot to ensure that no photodamage or sample movement occurred. In
extremely rare cases of photodamage ormovement, a new location is selected.
Statistical analysis
Statistical comparisons between pairs are carried out using a two-tailed
Student’s t-test. Significant differences across groups in the gel study for
lcell are determined by an ANOVA (Systat; Systat Software, Chicago, IL).
A probability of <0.05 was considered statistically significant for all
comparisons. All data are presented as mean5 standard error (SE).
Equations
Tortuosity (l), a measure of diffusive hindrance due to an effective increased
path length (15,16), is defined as the square root of the ratio of the diffusion
coefficient in free solution (Daq) over that in a gel or tissue (Deff):Biophysical Journal 97(1) 330–336l ¼ Daq=Deff
0:5
: (1)
(Tortuosity can alternatively be defined as a simple ratio (17,18), leading to
the same end result.) Rearranging, we show that tortuosity is a proportional-
ity factor that relates the measured effective diffusion coefficient (Deff) to
that in free solution (Daq):
Daq ¼ l2Deff : (2)
The contribution to effective diffusion at long length scales obtained using
SFA-FRAP contains the effects of cell geometries, eliminating direct paths
for diffusion and hindrance from interstitial matrix molecules. Thus, the
tortuosity measured by SFA-FRAP (lSFA) can be considered the product
of the individual tortuosities due to these factors, cellular exclusion (lcell)
and interstitial matrix (lint):
lSFA ¼ lcelllint: (3)
The cellular hindrance (lcell) is often referred to as geometric tortuosity in
the literature.
The diffusion measured by MP-FRAP at high spatial resolution within the
extracellular space only probes hindrance due to the interstitial matrix.
Therefore, the tortuosity quantified by MP-FRAP (lMP) is a direct measure
of the interstitial tortuosity:
lMP ¼ lint: (4)
MS-FRAP directly calculates the cellular hindrance from the ratio of the
SFA-FRAP and MP-FRAP tortuosities:
lcell ¼ lSFA=lMP ¼ lcelllint=lint: (5)FIGURE 1 Characterization of MS-FRAP. (A) Experimental setup. Arrows designate directionality (colored lines) along optical paths. (B) In vivo schematic
of multiscale measurement regions for each MS-FRAP component (MP-FRAP and SFA-FRAP) overlaid on an MPM image (white, interstitial matrix; black,
cells). Scale bar¼ 30 mm. (C and D) Bleach volumes in 10% agarose containing FITC-dextran2M after a single bleach from each FRAP modality. Axial (left)
and radial (right) profiles are shown with overlaid Gaussian fits. Loss of fluorescence appears where bleaching occurred. The bleach volumes at both scales are
axially confocal and radially concentric. Scale bars ¼ 1 mm in C, 10 mm in D.
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MS-FRAP measures multiscale diffusion in
confocally concentric volumes
We developed MS-FRAP on a custom-built multiphoton
microscope modified with an Argon laser for SFA-FRAP
and an electro-opticmodulator forMP-FRAP (Fig. 1,A andB).
We determined the MP-FRAP bleach volume dimensions
(1/e2) as 0.540 5 0.087 mm radially and 5.99 5 0.34 mm
axially, by multiphoton imaging after a single bleach (n ¼ 4)
in 10% agarose containing FITC-dextran2M (Fig. 1 C).
By imaging subresolution fluorescent beads, the multiphoton
point-spread functions (1/e2) were determined to be 0.5325
0.146mmradially and3.8250.32mmaxially, slightly smaller
than the bleach volume along the optical axis. The SFA-FRAP
bleach volume is much larger than the multiphoton technique,
with a radius of 15.95 0.3 mm at the focal waist (Fig. 1 D).
Importantly, the optical axis was identical for both techniques
and Gaussian fits of the bleach volumes showed the focal
planes differed by<0.5mm (Fig. 1,C andD).We further char-
acterized the MP-FRAP bleach volume in aqueous solution,
gels, and in vivo to show that bleaching was in the nonlinearregime (two-photon) without saturation for laser powers
<60 mW at the sample (Fig. S3). Additionally, photodamage
was shown to occur at bleach powers>70 mW; therefore, all
MP-FRAP studies in vivo used ~40 mW.
MS-FRAP measures accurate diffusion
coefﬁcients in one- or two-phase systems
We validated MS-FRAP using in vitro solution- and gel-
based systems. For multiscale measurements, we defined
working ranges for free FITC, FITC-IgG, and FITC-dextran
(2 MDa) in solution to be concentrations above 0.1 mM
(Fig. S4). Because the MP-FRAP component of MS-FRAP
has a high resolution and signal/noise ratio, we investigated
the ability of MP-FRAP to resolve diffusion due to two
phases (Fig. 2, A and B). Using a gel (5% agarose) and solu-
tion (aqueous) interface (gel-sol) system (Fig. 2 C), we
studied the diffusion of FITC-IgG between physical phases.
For comparison, we also measured diffusion in this system
with MP-FCS, whose ability to measure multicomponent
diffusion is well established in vitro (19). At the gel-sol inter-
face, both techniques were able to measure two separateFIGURE 2 Resolving two diffusing components with
MS-FRAP. (A) For MP-FRAP in vivo, a single-component
recovery model shows poor fits at early time points. (B) A
two-component model is able to fit recovery curves well,
with lower Gaussian-distributed residuals (not shown).
Accurate fitting to early time points is critical because the
greatest signal/noise ratio exists during initial recovery of
fluorescence. The abscissa is plotted on a logarithmic scale
to highlight the temporal dynamics of the initial recovery.
(C) Multiphoton-FRAP measured the diffusion coefficients
for FITC-IgG at the interface between two physical phases
(agarose gel and aqueous solution). (D) Diffusion coeffi-
cients at the interface determined by a two-component
fluorescence recovery model were statistically indistin-
guishable from diffusion measured solely within either
phase (gel, p ¼ 0.83; solution, p ¼ 0.37). (E) For compar-
ison, diffusion coefficients were determined by MP-FCS,
known to resolve two-component diffusion. Diffusion
coefficients measured by MP-FCS at the interface are
not statistically different from those shown in D (gel,
p ¼ 0.28, solution, p ¼ 0.15). For each bar, n ~ 9.Biophysical Journal 97(1) 330–336
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and pure solution (Fig. 2, D and E). These results suggest
that MP-FRAP can differentiate two diffusion coefficients
separated by at least a factor of 2.
Hyaluronan enhances diffusion in collagen/
hyaluronan networks
Collagen and hyaluronan are important for interstitial diffu-
sion and may influence its two-phase properties (8), but
understanding how their physical interactions determine
physiological macromolecular diffusion phenomena will
clarify how to overcome interstitial diffusion barriers. To
explore these properties, we applied MS-FRAP in a defined
in vitro system confounded by microheterogeneities (20)
and in vivo. We compared diffusion of FITC-IgG in
collagen/hyaluronan mixed gels with different collagen and
hyaluronan content (Fig. 3, A, C, and E). Increasing collagen
content hinders diffusion in the fast phase (p< 0.05, Fig. 3C)
and produces an increase in the slow diffusing fraction
(p < 0.01, Fig. 3 E). The addition of hyaluronan to collagen
gels reduced the diffusion in the fast phase as expected (p <
0.05, Fig. 3C), but interestingly it increased the fast diffusing
fraction (p< 0.01, Fig. 3E). Thus it seems that the interactions
between collagen and hyaluronan have complex effects on
molecular diffusion. Increasing collagen content expands
the slow phase thereby compacting and increasing viscousBiophysical Journal 97(1) 330–336hindrance in the fast phase. In contrast, adding hyaluronan
replaces water-filled pores, swelling the fast phase while
increasing viscous hindrance.We alsomeasured the diffusion
of FITC-IgG with MS-FRAP in normal skin (subcutaneous
muscle), and LS174T and HSTS26T tumors implanted in
DSC in male SCID mice (Fig. 3, B, D, and F). SFA-FRAP
measured a 3.5-fold greater diffusion coefficient in the normal
versus tumor tissue (p < 0.01, Fig. 3 B), whereas MP-FRAP
measured no significant difference in either phase for any
tissue (Fig. 3 D). Measured diffusion coefficients in the two
phases in gels and in vivo are similar in magnitude suggesting
analogous barriers to diffusion exist at short length scales. A
comparable trend of phase fractions is observed for normal
tissue versus LS174T (p < 0.05) and for HSTS26T versus
normal tissue (p < 0.01) and LS174T (p < 0.05), possibly
because of differences in collagen/hyaluronan content previ-
ously reported (21–23). These comparisons indicate that the
interactions of collagen and hyaluronanmay play a significant
role in interstitial diffusion in vivo, with the paradoxical
conclusion that, unlike with collagen (24), degradation of
hyaluronan may hinder diffusive transport for nanomedicine.
MS-FRAP distinguishes the interstitial and cellular
contributions to diffusive hindrance
Because the influence of cells on diffusion has never
been directly measured, it is unclear whether interstitialA B
C D
E F
FIGURE 3 Diffusion coefficients measured byMS-FRAP
in gels and in vivo. (A) Increasing collagen lowers the effec-
tive diffusion rate quantified by SFA-FRAP (p < 0.01). (B)
SFA-FRAP shows a difference in vivo between normal and
neoplastic tissue (p < 0.01), but not between tumor types
(p ¼ 0.61). (C and E) Two-component diffusion of FITC-
IgG in gels at short path lengths. Generally, decreasing
collagen or increasing hyaluronan content reduced the
slow phase fraction, whereas the diffusion coefficients in
each phase were largely unaffected. Collagen gels lacking
hyaluronan demonstrated a greater diffusion coefficient in
the fast phase and larger slow phase fraction. (D and F)
In vivo two-component diffusion of FITC-IgG. In D, no
significant difference is observed for either phase across
tissue types. In F, the slow diffusing fraction shows differ-
ences between tissue types. A similar trend of phase fractions
is seen as in the gels (matched shading), possibly due to
differences in estimated collagen/hyaluronan content.
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tissue. Considering the multiple length scales probed by
MS-FRAP in vivo, it is apparent that the MP-FRAP compo-
nent measures within the interstitial matrix (assuming no
cellular uptake of fluorescent probe), whereas the SFA-
FRAP component investigates regions that include several
cells in addition to interstitial matrix. Recognizing this fact,
we can directly measure the cellular hindrance (geometric
tortuosity in the literature) of a tissue by comparing the diffu-
sion coefficients from SFA-FRAP and MP-FRAP (weighted
average of the two phases) obtained by confocal measure-
ments (equations in Materials and Methods). The tortuosities
(l¼ (Daqueous/Dsample)0.5) in gels on both length scales ranged
from 1.5 to 1.6 for the low collagen gels to 2.5 for the high
collagen gel (Fig. 4, A and D). As expected, because of their
acellular nature, the cellular hindrance (ratio of the scaled
tortuosities) was close to 1 (p ¼ 0.85) across gels (Fig. 4 G).
Reducing cellularity enhances interstitial
transport in vivo
To understand cellular hindrance in vivo, we determined the
multiscale tortuosities for subcutaneous muscle and
HSTS26T and LS174T tumors. At the tissue level, MS-
FRAP measured a higher mean tortuosity in tumors and
nearly equivalent tortuosity in normal tissue versus gels
(Fig. 4 B). Within the interstitial matrix, only the soft-tissuesarcoma (HSTS26T) demonstrated a significantly higher
tortuosity (p < 0.01) than the other tissue types possibly
due to a higher collagen content (21–23) (Fig. 4 E). From
these results, measured cellular hindrances showed diffusion
in tumor tissue is further hindered by cells in contrast to gels
(Fig. 4 H). Tumors showed greater diffusive hindrance than
muscle (p < 0.05), where no cellular hindrance is detected
given the anisotropy of muscle fibers (Fig. S5). To assess
the effect of targeted cellular therapy on diffusion, we treated
mice bearing LS174T tumors in the DSC with diphtheria
toxin to induce apoptosis of the xenografted human tumor
cells while leaving the murine tissue unaffected (25). Treat-
ment showed a significant decrease in cellular hindrance
from 1.49 to 1.15 (p ¼ 0.01, Fig. 4 I). Therefore, decreasing
tumor cellularity reduced the hindrance to macromolecular
diffusion.
CONCLUSION
MS-FRAP facilitates the simultaneous measurement of the
hindrance to transport from tissue components of different
length scales, permitting characterization of multiple diffu-
sion barriers in a given tissue. Our results suggest that the
interstitial matrix and cells both hinder diffusion, and that
reducing collagen levels and cell density—but not hyalur-
onan levels—in tumors should enhance drug transport.






FIGURE 4 Measured tortuosity (l) by
MS-FRAP in gels and in vivo. (A, B, D
andE) Path-length dependent tortuosities
in interstitial matrix-mimetic gels and
in vivo tissue.MP-FRAPmeasures diffu-
sion in the interstitial matrix between
cells while confocally concentric SFA-
FRAP probes both the interstitial spaces
and cellular geometries. Tortuosity >1
indicates increased hindrance to diffu-
sion. Higher collagen content in gels
increases the interstitial tortuosity (lint),
or interstitial hindrance, reflected in
both lSFA (A) and lMP (D) (p < 0.01).
A similar effect is observed with lMP in
E between tumor types previously shown
to differ in collagen content (p < 0.01).
There is a pronounced difference in
lSFA between the normal tissue and the
tumors shown in B (p < 0.01). (G)
Cellular hindrance (lcell), defined as the
geometric tortuosity in the literature,
across gels is nonexistent (lcell ~ 1) due
to acellularity (p ¼ 0.85). (H) Diffusion
in normal subcutaneous muscle demon-
strates a cellular hindrance near 1 given
the anisotropic arrangement of muscle
fibers, whereas those in LS174T
(p < 0.01) and HSTS26T (p < 0.05) are
significantly greater suggesting increased
cellularity. (C, F and I) Selective cytotoxic treatment of mice bearing LS174T tumors with diphtheria toxin showed a significant decrease in cellular hindrance
(p ¼ 0.01), which arises from a decrease in lSFA (p < 0.01) but not in lMP (p ¼ 0.39) because the matrix is not affected. Tortuosity >1 indicates increased
hindrance to diffusion. For each group, n ¼ 3 in gels and n ¼ 4 in vivo.Biophysical Journal 97(1) 330–336
336 Chauhan et al.molecular and cellular constituents would represent a power-
ful strategy for improving the distribution and, in turn, effec-
tiveness of molecular anti-cancer therapies.
Considering the advantages of the multiscale approach to
studying diffusion in vivo, the MS-FRAP technique repre-
sents what we believe is a significant advance. We expect
that MS-FRAP will be applicable in numerous fields from
neuroscience to cancer biology to facilitate highly mecha-
nistic studies of diffusive hindrance in tissues.
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